Vyome Holdings, Inc
VT - 1953
symptoms of malignant fungating wounds
Countdown
1454days
Approval decision · ~ Jun 30, 2030 estimated
What's at stake
A final FDA approval decision on VT - 1953 for symptoms of malignant fungating wounds is expected ~ Jun 30, 2030.
Primary source
· SEC 8-K
verified 15h ago
“Phase 3 Completion Commercial Approval H1 2030”